New COVID treatment: TidalHealth will offer drug Bamlanivimab

BERLIN — Starting Dec. 1, TidalHealth became a regional referral site for the administration of a new COVID-19 treatment that drew attention when it was used to treat COVID-19 in President Donald Trump. Bamlanivimab, a monoclonal antibody produced by Eli Lilly & Co., was granted emergency use authorization by the Food & Drug Administration on […]